ஐவர் மக்ல்ந்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Athersys Partner HEALIOS K K Completes Enrollment in the TREASURE Study of MultiStem Treatment for Ischemic Stroke
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Athersys and HEALIOS K K Announce Advancement of Their MultiStem Commercial Partnership
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Readying For Commercialization
By Ivor Macleod
Commercialization in any industry requires detailed planning. For a biopharmaceutical company, this level of planning is particularly important in today’s continuously evolving marketplace.
Not only do you have to manage and allocate capital appropriately but also manage and mitigate the inherent risks in the process to the extent possible.
Signing up provides unlimited access to:
Trend and Leadership Articles
Not yet a member of Life Science Leader? Register today.
Email
Login Information
Business/Investment/Venture Capital/Legal
Consulting
COOK ISLANDS
HONDURAS
KOREA, REPUBLIC OF
LATVIA
MADAGASCAR
SAMOA
SPAIN
URUGUAY Continue
Subscriptions
Sign up for the newsletter that brings you the industry s latest news, technologies, trends and products.
Athersys Reports First Quarter 2021 Results
Search jobs
Management to host conference call at 4:30 pm EDT today
CLEVELAND (BUSINESS WIRE) $ATHX#Athersys Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended March 31, 2021 and provided a corporate update.
“Since our recent call, we remain on track with respect to our operating plans,” stated Mr. William (B.J.) Lehmann, Jr., Interim Chief Executive Officer of Athersys. “We look forward to important progress during the remaining course of the year, including expected top-line results from the TREASURE and ONE-BRIDGE studies in Japan.”
“Additionally, we remain focused on important priorities for the year, which include advancing our MASTERS-2 study and other clinical programs, supporting our partner, Healios, as it prepares for important regulatory applications, and in further developing our commercial manufacturing processes and planning,” added Mr. Lehmann.
Athersys Reports First Quarter 2021 Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.